Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2023
Provides updated key priorities and focus on enterprise value framework Closing of Jazz Pharmaceuticals (Jazz) collaboration in fourth quarter completes financial transformation initiatives originally planned for 2022 Announces additional financial